Stay updated on Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Sign up to get notified when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.

Latest updates to the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a newer build of the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3, indicating a small backend/template update.SummaryDifference0.0%

- Check42 days agoChange DetectedThe study record now indicates that participant recruitment has ended, and the page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a labeling update for Intervention/Treatment and a version bump to v3.6.0.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a new patch or update to the study record display. This is a technical metadata update that does not alter the study data or visible content.SummaryDifference0.0%

- Check64 days agoChange DetectedAdds a new bibliographic reference to the Publications section for a 2024 Osteoarthritis Cartilage article on preexisting articular bone pathology in OA patients screened for fasinumab, with the listed authors.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a platform or documentation version update. This update does not modify the study details, eligibility criteria, or results; it reflects backend/UI maintenance.SummaryDifference0.0%

Stay in the know with updates to Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety&Efficacy of Fasinumab vs Placebo&NSAIDs in OA Clinical Trial page.